AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. They are redefining interventional therapy for severely calcified lesions with their Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device. 

Manufacturing

Medical Devices

Mark Toland

Sean Gilligan

Beatriz Vendrell-Velez, MPH

Susie McAfee, SPHR, SHRM-SCP

Robert Lavado

Robert Chisena

Board and Advisory Roles

Leadership Team

Engineering Team

Quality Assurance and Regulatory Affairs

Teams at AVS

Board and Advisory Roles

Leadership Team

Engineering Team

Quality Assurance and Regulatory Affairs